Juergen Volz

Title: Juergen Volz: Innovator in Phosphodiesterase Inhibitors

Introduction

Juergen Volz is a notable inventor based in Radolfzell, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of phosphodiesterase inhibitors. With a total of 2 patents, his work has implications for various therapeutic applications.

Latest Patents

Juergen Volz's latest patents focus on pyrazolone derivatives as PDE4 inhibitors. One of his notable compounds is 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione, which has been identified as a novel effective inhibitor of type 4 phosphodiesterase. Additionally, he has developed compounds of a certain formula that serve as effective inhibitors of the same enzyme, showcasing his innovative approach to drug development.

Career Highlights

Throughout his career, Juergen Volz has worked with prominent companies in the pharmaceutical industry, including Nycomed GmbH and Takeda GmbH. His experience in these organizations has allowed him to refine his expertise in drug discovery and development.

Collaborations

Juergen has collaborated with several professionals in his field, including Beate Schmidt and Christian Scheufler. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Juergen Volz is a distinguished inventor whose work in phosphodiesterase inhibitors has the potential to impact therapeutic strategies significantly. His innovative contributions and collaborations highlight his commitment to advancing medicinal chemistry.